Cargando…
Fragment-Based Lead Discovery Strategies in Antimicrobial Drug Discovery
Fragment-based lead discovery (FBLD) is a powerful application for developing ligands as modulators of disease targets. This approach strategy involves identification of interactions between low-molecular weight compounds (100–300 Da) and their putative targets, often with low affinity (K(D) ~0.1–1...
Autores principales: | Konaklieva, Monika I., Plotkin, Balbina J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951956/ https://www.ncbi.nlm.nih.gov/pubmed/36830226 http://dx.doi.org/10.3390/antibiotics12020315 |
Ejemplares similares
-
Utilization of Existing Human Kinase Inhibitors as Scaffolds in the Development of New Antimicrobials
por: Konaklieva, Monika I., et al.
Publicado: (2023) -
Impact of host factors on susceptibility to antifungal agents
por: Plotkin, Balbina, et al.
Publicado: (2022) -
In silico Strategies to Support Fragment-to-Lead Optimization in Drug Discovery
por: de Souza Neto, Lauro Ribeiro, et al.
Publicado: (2020) -
Molecular Targets of β-Lactam-Based Antimicrobials: Beyond the Usual Suspects
por: Konaklieva, Monika I.
Publicado: (2014) -
Current perspectives in fragment-based lead discovery (FBLD)
por: Lamoree, Bas, et al.
Publicado: (2017)